Sanofi at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Sanofi brings 5 presentations to SfN 2026 in Washington. Its program at this meeting centres on neurodegeneration and TDP-43, neuroinflammation, and sleep and circadian changes. One thread examines how TDP-43 changes affect astrocyte gene processing and metabolic and circadian function.

Organization	SfN 2026 Attendance
Sanofi Cambridge, MA
sanofi.com Drug developers Pharmaceutical company conducting research and developing medicines, including neuroscience research.	Poster Sat Nov 14 1–5pm Part of Session PSTR014: ALS and Motor Neuron Diseases: In Vitro Studies TDP-43 loss-of-function in astrocytes drives cell-type-specific cryptic exon dysregulation, and is amplified by NMD inhibition WCC Halls A-C · Board X5 Poster Sun Nov 15 8am–noon Part of Session LBP002: C.02. Alzheimer's Disease and Other Dementias The EPND Consortium: Neuroinflammatory and Astrogliosis Signatures Distinguish Disease-Specific and Shared Molecular Pathways Across Neurodegenerative Diseases in CSF Proteomics WCC Halls A-C · Board B70 Poster Mon Nov 16 1–5pm Part of Session PSTR192: Sleep Regulation: Anatomy, Pharmacology, Behavior Orexin/ataxin-3 model mice show sleep and neurochemical phenotypes reminiscent of narcolepsy type I (NT1) WCC Halls A-C · Board FF2 Poster Tue Nov 17 8am–noon Part of Session PSTR224: Stroke, Ischemia, and Vascular Injury: Mechanistic Studies Characterizing Acute Neuroinflammation and Microglial Response Following Ischemic Stroke WCC Halls A-C · Board X30 Poster Wed Nov 18 8am–noon Part of Session PSTR309: ALS and Motor Neuron Diseases: Human Genetics, Cellular Mechanisms, and Animal Models TDP-43 Q331K overexpression leads to perturbed metabolic and circadian function in a mouse model WCC Halls A-C · Board Y19

Organization

SfN 2026 Attendance

Sanofi

Cambridge, MA

sanofi.com

Drug developers

Pharmaceutical company conducting research and developing medicines, including neuroscience research.

Poster

Sat Nov 14
1–5pm

Part of Session PSTR014: ALS and Motor Neuron Diseases: In Vitro Studies

TDP-43 loss-of-function in astrocytes drives cell-type-specific cryptic exon dysregulation, and is amplified by NMD inhibition

WCC Halls A-C · Board X5

Poster

Sun Nov 15
8am–noon

Part of Session LBP002: C.02. Alzheimer's Disease and Other Dementias

The EPND Consortium: Neuroinflammatory and Astrogliosis Signatures Distinguish Disease-Specific and Shared Molecular Pathways Across Neurodegenerative Diseases in CSF Proteomics

WCC Halls A-C · Board B70

Poster

Mon Nov 16
1–5pm

Part of Session PSTR192: Sleep Regulation: Anatomy, Pharmacology, Behavior

Orexin/ataxin-3 model mice show sleep and neurochemical phenotypes reminiscent of narcolepsy type I (NT1)

WCC Halls A-C · Board FF2

Poster

Tue Nov 17
8am–noon

Part of Session PSTR224: Stroke, Ischemia, and Vascular Injury: Mechanistic Studies

Characterizing Acute Neuroinflammation and Microglial Response Following Ischemic Stroke

WCC Halls A-C · Board X30

Poster

Wed Nov 18
8am–noon

Part of Session PSTR309: ALS and Motor Neuron Diseases: Human Genetics, Cellular Mechanisms, and Animal Models

TDP-43 Q331K overexpression leads to perturbed metabolic and circadian function in a mouse model

WCC Halls A-C · Board Y19

Instantly find 20 buyers from Sanofi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction